Reveal the invible. Transforming cancer care with early detection Cyberna is developing innovative in vitro diagnostic (IVD) tests for early detection of cancer through a simple blood drop IVD, DMDIV, epitranscriptomic, machine learning, IA, mass spectrometry, RNA chemical modification , RNA, cancer, colorectal cancer, screening, and early detection

110 similar entities Type: Startup Activities: deeptech biotech Technologies: A.I.

Development of innovative neurological therapeutics based on pannexin channels Panntherapi develops innovative drugs in Neurology by acting on a specific target, the activated pannexin 1 channel, aiming a better efficacy and tolerance than current drugs. Panntherapi offers breakthrough innovation for the two main issues in development of current drugs in neurological diseases: - Innovative target addressing the root cause of the diseases - Representative non-clinical model using among others ex vivo human brain tissues Biotech, Neurology, Epilepsy, and Deeptech

114 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Targeted imaging and therapies Zionexa is an international and innovative company developing and commercializing molecular imaging solutions, in-vivo biomarkers for targeted therapies in oncology, to improve patients’ pathway and bring them a better quality of life. Molecular Imaging, Oncology, Targeted therapies, CDx, Radiopharmaceuticals, and Biomarkers

73 similar entities Type: Startup Activities: biotech deeptech

Digital Medicine 🌍 MedicoTech is a software publishing company in the medical field 👩‍⚕️. Our products OncoClic📱an app for healthcare professionals and ACTIS oncology🔎 a clinical trial search engine that allows you to find a clinical trial in < 1 minute! More than 8,000 professionals use our services. Join us! Medicine, Oncology, and Clinical Research

303 similar entities Type: Startup Activities: healthtech deeptech Technologies: SaaS

New treatments for central nervous system disorders Neurolixis Inc. is a biopharmaceutical company focused on the discovery and development of novel drugs for the treatment of human central nervous system diseases including movement disorders, autism spectrum disorders, depression and pain. Neuroscience, Drug development, Parkinson's disease, Biased agonism, Orphan Drug, Autism, and Serotonin

179 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Creating a new path for neurodegenerative diseases Tetraneuron is a drug discovery company, focused on the development of a disruptive gene therapy for Alzheimer’s Disease (AD) and an Early Biomarker for this neurodegenerative condition. alzheimer, terapia genica, gene therapy , disruptive therapy, Alzheimer´s Disease, Biomarker, neurodegenerative disease, neuroscience, neurociencia, enfermedades neurodegenerativas, neurodegeneration, dementia, and pioneering

138 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Cancer Genomic Testing & Molecular Diagnostics | Veracyte Inc. Veracyte is a global diagnostics company that empowers clinicians with the high-value insights they need to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. Our growing menu of diagnostic tests answers important clinical questions to help patients avoid risky, costly procedures and interventions, and accelerate time to appropriate treatment.

67 similar entities Type: Startup Activities: biotech deeptech

Cloud Based Haematology Diagnostics Delivered aaS RheoDx is a diagnostics company committed to improving the quality of life of hematology patients and the efficiency in their clinical management. Develops an inexpensive medical device that monitors red blood cells conditions in less than five minutes with a drop. Its small size and simplicity allow to be used at the point-of-care and at home. Spin-off of the Centre Recerca Matemàtica (CRM), and incorporated in the Collider, the venture builder of tech transfer by Mobile World Capital Foundation. Medical Devices, In vitro diagnostics, Hematology, Point-of-care, Transfusions, and Blood cells conditions

202 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Accelerating clinical trial matching in oncology Deep Lens is a digital healthcare company focused on enabling faster recruitment of the best-suited cancer patients for clinical trials at the time of diagnosis using VIPER. Deep Lens’ AI-driven cloud platform gives care teams, trial coordinators and oncologists visibility into all available trials and the ability to collaborate on groundbreaking cancer research across all cancer types. Artificial Intelligence, Pharmaceuticals , Cancer Research, Oncology, and Pathology

88 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: A.I.

Cutting-edge drugs for calcium-related diseases An innovative SME founded in December 2016 and committed to the discovery and development of orphan drugs for patients affected by calcium-related genetic diseases. ChemiCare’s mission is the improvement of the quality of life of patients affected by rare diseases such as Duchenne Muscular Dystrophy and Tubular Aggregate Myopathies, and autoimmune disorders by the development of a therapy that restores the abnormal intracellular calcium level, a common feature of these diseases. biotechnology, orphan disease, calcium-related disease, and rare disease

81 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Endomag is a medical technology company devoted to improving the global standard of cancer care. Our Sentimag® system, Magseed® marker and Magtrace® lymphatic tracer are used by thousands of the world’s leading physicians and cancer centres. Our goal is to help women with breast cancer avoid surgery when it isn’t needed, and experience better outcomes when it is. We’ve helped tens of thousands of women around the world access more precise and less invasive breast cancer care. Founded in 2007 as a spin-out from the University of Houston and the University College London (UCL), we continue to develop our unique …

194 similar entities Type: Startup Activities: healthtech deeptech Technologies: SaaS

Dive into deep brain oscillations Quantitative analyses of EEG signals for the management of drug-resistant epilepsy We provide Halyzia®, a powerful software to review intracranial EEG and extract biomarkers of epilepsy, such as high-frequency oscillations and epileptic spikes. We also provide quantitative analyses services in research projects, transforming raw data into immediate actionable insights. Epilepsy, Biomarker, SEEG, and Fast ripple

112 similar entities Type: Startup Activities: deeptech Technologies: A.I.

Our mission is to make healthcare more affordable and accessible through the power of Artificial Intelligence Qure.ai is a health tech company that uses deep learning and Artificial Intelligence (AI) to make healthcare more accessible and equitable for patients worldwide. Our solutions power the efficient identification and management of Tuberculosis (TB), Lung Cancer and Stroke to support clinicians and propel developments in the pharmaceutical and medical device industries. We empower healthcare by helping to identify conditions fast, prioritize treatment planning and ultimately improve the quality of patient life. Deep learning, Healthcare, Digital Radiology, Medical Imaging, Artificial Intelligence, Workflow Optimisation, Lung …

246 similar entities Type: Startup Activities: healthtech deeptech Technologies: A.I. - Deep Learning A.I. IoT Sensors

Neuroprotecting Patient's Future Saxol, newborn company develops innovative compounds able to fight and/or to prevent peripheral neuropathies, including Diabetes peripheral neuropathies, Immuno and Chemotherapy-Induced Peripheral Neuropathies (CIPN). Based on IAB research on Carbazole structure (Lafanechère Team) and with the support of Linksium, we plan to bring to patients, new neuroprotective drugs to answers current Unmet Medical needs CARBA1, our lead compound has neuroprotective activity through a mechanism of regulation and reactivation of energy production at the cellular level. We plan first to develop Carba1 for CIPN Unmet Medical Need and to enlarge after to Diabetes Peripheral Neuropathy DPN and other …

98 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

See beyond appearances Damae Medical is reinventing skin imaging, revolutionizing the screening, management, and follow-up of skin cancers (melanoma and carcinoma) with its deepLiveTM solution, which provides an accurate, fast and reliable optical examination without performing a biopsy. CE marked, the deepLiveTM medical device is based on LC-OCT (Line-field Confocal Optical Coherence Tomography) proprietary optical imaging technology that provides 3D images of the different layers of the skin at the cellular level, complemented by several software and Artificial Intelligence (AI) modules. This innovation is protected by 6 patent families and has already been published in more than 100 scientific and …

216 similar entities Type: Startup Activities: healthtech deeptech Technologies: A.I.

EEG made simple, anywhere NaoX Technologies is a French startup launched in 2018 by Hugo DINH, Polytechnician and Michel LE VAN QUYEN, neuroscience expert at Inserm. Our mission is to democratize the prevention of neurological disorders. Neuroscience, IOT, and Health & Well-being

170 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: IoT

Unlocking the full potential of cancer therapy with at-home blood monitoring Entia is an oncology service provider supporting more effective cancer care by predicting and preventing treatment side effects. Our unique remote patient monitoring solutions, including the world's first at-home full blood count analyser, identify patients at risk of complications early on and enable timely interventions that can result in more time on treatment, fewer unplanned hospitalisations and the potential deliver better survival outcomes. We're proud to be partnered with some of the largest global oncology centres and supporting blockbuster therapies from industry leaders. Together, we're unlocking the full potential …

118 similar entities Type: Startup Activities: healthtech deeptech Technologies: A.I.

Reversing Alzheimer's disease symptoms Neurocia is a medtech developing non-invasive medical device allowing stabilizing and reversing symptoms of Alzheimer's disease Alzheimer's disease and Medtech

117 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

MDinc is a developer of neurological and cognitive AI-powered products MDinc is a modern medtech company, the developer of neurological and cognitive AI-powered products. We encompass solutions for people with nervous system disorders by coupling computer vision, machine learning and medical expertise to provide personalized digital therapies. NeuroTech, Healthcare, and MedTech

142 similar entities Type: Startup Activities: deeptech Technologies: A.I.

Pioneering prediction and prevention in dermatology SciBase is a global medical technology company, specializing in early detection and prevention in dermatology. SciBase develops, manufactures and commercializes Nevisense, a unique point-of-care platform that combines AI (augumented intelligence) and advanced EIS technology to elevate diagnostic accuracy, ensuring proactive skin health management. Our commitment is to minimize patient suffering, allowing clinicians to improve and save lives through timely detection and intervention and reduce healthcare costs. Built on more than 20 years of research at Karolinska Institute in Stockholm, Sweden, SciBase is a leader in dermatological advancements. The company has been on the Nasdaq …

86 similar entities Type: SMB Activities: deeptech biotech Technologies: A.I.

Follow us at Shionogi Inc. for news about our rare disease research programs https://www.linkedin.com/company/shionogi-inc-/ drug discovery, PDE4D, PDE4B, Fragile X, CTE, Rubinstein-Taybi, traumatic brain injury, Clinical Trials, Fragile X syndrome, Cognition, BPN14770, and Memory Loss

364 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

NEW FRONTIERS IN NEUROSCIENCE Neurentis PLC is a late-clinical stage UK specialty pharma company, focusing on neuroscience and specialising in the development of novel treatments for mental health and other neurological and psychiatric diseases. Our product pipeline is balanced with an advanced lead drug for the treatment of Treatment-Resistant Depression (TRD) in the last stages of drug development as well as earlier stage drug candidates in collaboration with research institutions and other companies. The company is run by experienced ex-pharma industry executives, with more than 35 years’ experience in the sector each. The company’s low-risk commercial strategy is to commercialize …

382 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Pioneering a new era in precision medicine for women's health A clinical-stage biotechnology company pioneering a female-focused precision medicine approach using validated biobanks for the discovery, development, and commercialization of novel therapeutics and companion diagnostics in women's health. ovarian cancer, endometrial cancer, fibrosis, endometriosis, post surgical adhesions, surgery, women's health, fitness, health, lifestyle, precision medicine, Artificial Intelligence, Machine Learning, Biobank, gynecology, reproductive medicine, infertility, cervical cancer, pcos, femtech, life sciences, and healthcare

301 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology A.I.

Gain actionable insights to confidently advance every step of your oncology drug development programs. Veracyte is a global diagnostics company that empowers clinicians with the high-value insights they need to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. We provide novel insights, expertise and capabilities that empower our biopharmaceutical partners to confidently advance every step of their oncology drug development programs. precision medicine, Biopharma, biomarker signatures, and Cancer care

107 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. Data Analytics

Advanced Brain Therapy Carthera® is a clinical-stage medtech company focused on developing innovative ultrasound-based medical devices to treat a wide range of severe brain disorders. Carthera® has developed a proprietary device called SonoCloud®- a groundbreaking medical device that emits ultrasound to temporarily increase the permeability of the blood vessels in the brain. By using SonoCloud®, the therapeutic efficacy of new and existing therapies can be unlocked and harnessed to improve the treatment of a wide range of brain diseases: oncology indications (glioblastoma, brain metastasis) or neurodegenerative diseases (such as Alzheimer’s Disease, ALS). The products developed by Carthera® are in clinical …

Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Developing groundbreaking treatments for Alzheimer’s disease, pain conditions and other severe CNS disorders. Learn more AlzeCure Pharma is a Swedish pharmaceutical company engaged in innovative drug research with a primary focus on Alzheimer’s disease and pain. The company is listed on Nasdaq First North Premier Growth Market and is developing five drug candidates based on the two research platforms, NeuroRestore and Alzstatin. The NeuroRestore platform comprises symptom-relieving drug candidates while Alzstatin comprises disease modifying and preventive drug candidates. A diversified portfolio of drug candidates that act on central signaling pathways in the brain also opens up for other indications such …

204 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Neuromodulation Simplified Neuronoff, Inc. is developing new medical devices utilizing neuromodulation to restore & improve organ activity in the human body. The primary focus is on treatments for chronic pain. Neuromodulation, DRG, Chronic Pain, PNS, and Stimulation

193 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Overcoming Parkinson's disease DiamPark is an R&D neurotech whose vocation is to characterize and achieve innovative solutions based on the capture, measurement and analysis of digital neuromarkers specific to Parkinson's disease. The offer is twofold, a patient support and monitoring program and a reliable digital evaluation tool for the progression of the disease and the therapeutic effects of drugs in real life and in R&D. Neurologie, Maladie de Parkinson, Neuromarqueurs digitaux, e-santé, Données cliniques, Données de vie réelle (RWE), Suivi longitudinal des patients, Parcours patient, Coordination des soins, Recherche clinique digitale, Data Science en santé, Dispositif médical numérique, Intelligence artificielle, …

134 similar entities Type: Startup Activities: deeptech healthtech Technologies: A.I. A.I. - Machine Learning

INNERVATE. SCREEN. TRANSLATE. NETRI is an Techbio industrial start-up whose mission is to improve human health through the discriminating power of the nervous system. The company offers a Neuron-as-a-sensor suite (NaaS) to gain insights into the safety and efficacy of clinical or chemical compounds. NETRI focuses on pain quantification and pursues an exploratory pipeline in oncology-related adverse events, dermo-cosmetics, neurological disorders and neurotoxicity. Leveraging the natural capacity of neurons to encode biological interactions into electrical impulses, the NaaS suite features the world-first compartmentalized electrophysiology platform in standard 96-well plate format - NeuroFluidicsTM MEA - which acts as a data generation …

92 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

The Trusted Source for Clinical Trial Information Since 1994, CenterWatch, A WCG Company has been the recognized global leader in providing clinical trials information to professionals working at sponsors, CROs, research sites and niche service providers. Today, WCG CenterWatch delivers critical industry insights to 150,000 life science executives every week through its newsletters, conferences, webinars, books, in-depth market surveys, industry profiles and clinical databases. And millions of patients and caregivers start their search for clinical trials with CenterWatch, with one of the largest clinical trial databases on the internet, CenterWatch iConnect. Clinical Trials Information, FDA Drugs Information, Clinical Research Market …

60 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology

Health monitoring made simple - powered by breath BOYDSense an award-winning start-up developing non-invasive breath analysis solutions to risk stratify, monitor and detect biomarkers for chronic conditions and diseases, focusing initially on Diabetes. We're a pioneering business (with corporate roots in Delaware, US) with a European headquarters located in Toulouse, France. We have additional operations in San Francisco. Our device is pain-free, very simple and intuitive and cost effective Healthcare, Med Tech, Metabolism, Metal Oxyde Sensors, Machine learning, Artificial Intelligence, Chronic conditions, Diabetes, and Blood Glucose levels

424 similar entities Type: Startup Activities: healthtech deeptech Technologies: Data Analytics

Seenel Imaging is dedicated to functional Neuroimaging technology. We launched in 2019 a breakthrough research device combining EEG & fNIRS further to 10 years of Academic research. Medelopt® is a wearable High Resolution NIRS/EEG device with unique features on the market. NIRS, EEG, Brain Imaging, Functional NIRS, Cognitive Research, Optical Imaging, Innovation, and Neuroscience

84 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Medical Center for Neurology and Neurosurgery Integrated neurological reference center with more than 20 neurologists and neurosurgeons, providing consultations, exams and procedures. A privileged structure to take care of your health with agility and convenience, and most importantly, the safety of renowned experts with the support of high technology. Clinical Neurology, Neurosurgery, Neuropediatrics, Neuroradiology, Butolin Toxin, Research Center, and Epilepsy

139 similar entities Type: SMB Activities: healthtech Technologies: Cybersecurity

Advanced Technologies for Neuromarkers of Brain Disorders NeuroKyma develops advanced AI-based technologies in the design and production of neuromarkers (neurophysiological measurement units) to understand how the brain functions. Historically positioned in the pharmaceutical and medical research market, NeuroKyma supports CROs and manufacturers in the pharmaceutical sector in their clinical trials. To do this, the company delivers neuromarkers based on High Resolution EEG. The company also offers other applications of its technology in the field of Health & Well-being (cosmetics, nutrition, sport and cognitive remediation in EHPADs). To this end, signal processing carried out from a classic EEG and associated biomarkers …

123 similar entities Type: Startup Activities: deeptech Technologies: A.I.

Minimally Invasive, Maximally Precise. DeepPulseNeuro is pioneering a new path in epilepsy care through endovascular brain monitoring, delivering greater precision, faster diagnosis, and renewed hope for cure.

59 similar entities Type: Startup Activities: deeptech healthtech

Forging a new era of highly targeted neuro therapies Our vision is to redefine the boundaries of neuroscience with minimally invasive technologies to enable unparalleled precision, enhance patient outcomes, and forge a new era of highly targeted neurotherapies for a healthier world.

70 similar entities Type: Startup Activities: healthtech deeptech

A precision medicine company solving the critical issue of inadequate cancer treatments Spotlight Medical is a French oncology diagnostics company developing evidence-driven, clinical-grade AI tests to support more precise treatment selection in cancer. True to its “science first” approach, the company prioritizes rigorous clinical validation and the design of explainable algorithms to deliver tangible, measurable benefits to patients.

270 similar entities Type: Startup Activities: deeptech healthtech Technologies: A.I.

Our purpose is to help millions of people living with heart failure to get their normal back. FIRE1 aims to improve patient quality of life, and patient outcomes, while lowering overall healthcare costs. Health Tech, Research & Development, Medical Devices, Software Engineering, and Clinical

84 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

Un ingrédient alimentaire innovant à base de clou de girofle pour la santé cognitive Aroma Therapeutics is a biotech company specialised in natural products for the prevention of brain diseases. Aroma Therapeutics has patented a scent diffusion technology for Olfactory Deep-Brain stimulation. In collaboration with well-known laboratories, the company is working on an ethno-botanical approach for : •babie's pain relief •memory improvement and prevention of Alzheimer Disease The company also provides tools for Brain Function & Sleep Enhancement. Santé, Aromathérapie, Phytothérapie, Extraction de plantes, Compléments alimentaires, Santé Cognitive, Senior, Nutraceutique, maladies du vieillissement, alzheimer, Médecine Traditionnelle Chinoise, and Nutraceutique

84 similar entities Type: Startup Activities: healthtech Technologies: Synthetic Biology

Precision Oncology Solutions CanCell Personalized Cancer Treatment Solutions helps you reach the most appropriate treatment option with comprehensive genetic analysis services and more.

62 similar entities Type: Startup Activities: deeptech

Denmark-based group of companies focused on production and distribution of OTC CBD medical devices and cosmetics. CS MEDICA is a group of two fully-owned, Denmark-based subsidiaries: Galaxa Pharma A/S and CanNordic A/S, whereby CanNordic A/S is a registered Medical Device product developer and Galaxa Pharma A/S is product distributor in the Nordic Region. We see ourselves as a company in constant development, exploring the ways in which we can support patients in their battle against the disease, the pain and the sorrow it brings. Medical Device, Pharmaceuticals, Cosmetics, Regulatory Affairs, Distribution, Manufacturing, Cannabinoids, and CBD

230 similar entities Type: Startup Activities: manufacturing deeptech healthtech Technologies: Synthetic Biology

Neem’s Hill is a holding company focused on investments and innovations in the medical device sector. Through its portfolio companies, it develops and commercializes patented Tumour Specific Electroporation (TSE) technology for cancer treatment. Today, the Group operates in both Human Care and Animal Care, with the ambition to improve clinical outcomes while reducing side effects through innovative, tissue-preserving cancer treatments. Cancer Treatments, Research, Clinical Development, Chemotherapy, and Immunotherapy

307 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Personalized medicine made simple with artificial intelligence DoMore Diagnostics uses artificial intelligence to make personalized treatment decisions simple and accessible for all cancer patients. Its unique digital biomarkers predict patient outcomes from routine tumor tissue slides and can be seamlessly integrated into pathologists’ existing workflow. The lead product Histotype Px® Colorectal is a CE-IVDD marked outcome prediction marker for stage II and III colorectal adenocarcinoma that informs the decision of whether to provide adjuvant chemotherapy following surgical resection of the tumor. The company is based on prominent international research from leading universities and funded by top Norwegian tech investors. Cancer, …

256 similar entities Type: Startup Activities: healthtech deeptech Technologies: A.I.

In vitro Slice Electrophysiology for CNS and Pain Research Neuroservice USA has been acquired by Neuroservices Alliance Please visit: https://www.linkedin.com/company/18799325 Drug Discovery, CNS, Electrophysiology, Pharmacology, Multi-Electrode Array, Patch-Clamp, Pain, Brain slices recordings, Safety, Toxicology, Neuropharmacology, CNS Research, CNS Preclinical Research, Preclinical Research, and CNS Electrophysiology

139 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Precisely where it matters Xeos is a MedTech start-up company that is focused on improving outcomes in Surgical Oncology through innovations in molecular intra-operative imaging. Our ultimate goal is to eliminate the risk for re-surgery through smarter specimen imaging.

137 similar entities Type: Startup Activities: healthtech deeptech Technologies: IoT

Better neurology care is here. Just ask the data. Backed by over a decade of Oxford research, Kneu transforms smartphones into clinical-grade monitors for neurological conditions, starting with Parkinson’s and dementia. By capturing subtle changes in movement, cognition, and wellbeing, our technology provides objective insights that go beyond self-reporting. This empowers people living with neurological conditions, supports clinicians in delivering more personalized care, and helps health systems in the UK and US reduce pressures while improving outcomes.

151 similar entities Type: Startup Activities: healthtech Technologies: SaaS

As a member of ONO Group, Deciphera is a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer. We are leveraging our proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines. For more information, visit www.deciphera.com.

157 similar entities Type: SMB Activities: biotech deeptech Technologies: SaaS

33 years of clinical research in pharmacy, medical device & amp; Dermo-cosmetics Quanta Medical Sharing experience Cro since 1986. 30 years of advice and operational services in clinical research and observational studies, 30 years of presence in Europe and on the African continent alongside the pharmaceutical, agro-food, dermatological, cosmetics and medical device, 30 years of human health know -how reinforced by: - a double ISO 9001 & amp; 27001 -dedicated technical tools (Quanta View®, E-CRF, Trial-on-Line®) Clinical research / Clinical trial, E-CRF, Epidemiological Study, Data Management / Biometrics, Medical Writing, Health IT development, Evaluation of health risks, and regulatory advice

467 similar entities Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

Rapid, instrument-free precision cancer diagnostics Panakeia offers an AI platform to enable simplified, rapid diagnostics to inform the precision treatment of cancer Machine Learning, Deep Learning, Artificial Intelligence, Cancer Diagnostic, and Personalized Medicine

154 similar entities Type: Startup Activities: deeptech biotech Technologies: A.I.

Build together COMEPA Industries has built its reputation by creating innovative technology-driven solutions, from space technology to high-performance medical instruments fabrics. Chirurgie, Anesthésie, Monitorage, Urologie, Ventilation, Intubation, Dispositifs médicaux, Spacial, Ferroviaire , Energie, and Thermostat

90 similar entities Type: SMB Activities: deeptech

A leading nationwide clinical research site network pursing life-changing therapies committed to better patient outcomes CenExel is a leading integrated, wholly owned, nationwide clinical research site network comprised of 18 Centers of Excellence in major metropolitan areas across the U. S. With 40+ years of experience, our Centers of Excellence deliver deep scientific expertise, premium data, operational efficiencies, and exceptional patient engagement to drive successful complex clinical trial outcomes. The world's most results-driven Pharma, Biotech, and Clinical Research Organizations trust our strategic approach and benefit from our collaboration and unified sites’ commitment to real world solutions. Rely on us to …

131 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Transforming Energy into Therapy Galvanize Therapeutics is developing therapies to deliver life-changing healthcare solutions to patients and their doctors at the convergence of biology, engineering, and care delivery. medical device, COPD, AF, Oncology, Intervential Oncology, Intervential Pulmonology, AFib, PEF, PEF Ablation, Soft Tissue Ablation, Cardiac Arrhythmias, and Chronic Bronchitis

451 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Creating innovative solutions with non-invasive technology Zedsen’s proprietary, non-invasive sensor aims to change the current paradigm of health and oncological care for the better. We are committed to addressing the Institute for Healthcare Improvement’s “Triple Aim'' for optimising healthcare systems, by enhancing the quality of care, improving the health of the overall patient population, and decreasing the cost of healthcare per capita. Sensors, Hardware, Firmware, Software, Innovation, Electronic design, Algorithms, Machine learning, Materials Science, Testing, Data science, Data analysis, Cancer, and Oncology

327 similar entities Type: Startup Activities: deeptech healthtech Technologies: A.I. A.I. - Machine Learning Data Analytics New Materials Sensors

Trusted partner offering integrated continuum services for medicinal products to access the french market #EAP #CUP #MA - French pharmaceutical company to support global pharma to access to the frenck market - Operate as your affiliate in France combining the exploitation, the distribution, the manufacturing & importation in a single integrated continuum process - Independent and family-owned company - Part of DESTAING PARTICIPATIONS GROUP Early Access, Exploitant services, Orphan drug, Rare disease, Distribution, Promotion, Compassionate, and Market Access

237 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology

The Azuréen Cancer Center (C.A.C) is a private establishment whose mission is to treat cancer conditions in adults and to give patients rapid access to the most appropriate treatments: radiotherapy, chemotherapy, immunotherapy, targeted therapies, The radiotherapy technical platform has 5 of the most recent particle accelerators which make it possible to offer modern radiotherapy techniques: stereotactic radiotherapy, intensity modulated radiotherapy, radiosurgery. Oncology, Cancerology, Radiotherapy, Chemotherapy, Immunotherapy, Stereotactic Radiotherapy, and Radiosurgery

84 similar entities Type: SMB Activities: deeptech healthtech Technologies: SaaS

Developing first in class therapies for the treatment of dementia. Cogentis Therapeutics is an early stage biotechnology company with a mission to develop and commercialize an innovative disease-modifying therapeutic for dementias such as frontotemporal dementia (FTD) and Alzheimer’s disease (AD) to improve patients’ quality of life and reduce the burden of disease on their families, providers, and the overall healthcare system. Our immediate goal is to develop a peptide-based compound, CT-526, for FTD. neurodegeneration, neuropeptide, frontotemporal dementia, Alzheimer's disease, and progressive supranuclear palsy

102 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Pour répondre aux enjeux de la médecine personnalisée, nous développons des solutions d’imagerie moléculaire innovantes pour l’aide au diagnostic et le suivi thérapeutique en oncologie, neurologie, cardiologie afin d’améliorer la qualité de vie des patients, la sécurité et l’efficacité thérapeutiques tout en réduisant les coûts. To meet the challenges of personalized medecine, we are developing molecular imaging solutions in oncology, neurology, cardiology which improve patients'​ quality of life, security and therapy efficiency, while reducing costs. radiopharmacy, healthcare, and oncology

149 similar entities Type: SMB Activities: deeptech healthtech Technologies: Cybersecurity

Better tech for mental health. A Superdevice for Mental Health OAK, the apex brain stimulation wearable for neuropsychiatric and cognitive health, is the result of 15 years of clinical research and product development, millions of hours of real-world testing, and a groundbreaking collaboration with the design and engineering teams behind Beats and Nest. Depression Treatment, Insomnia Treatment, Anxiety Treatment, sleep medicine, and stress management

184 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Improving diagnostic accuracy for cancer patients We combine world-leading scientific and medical expertise with cutting-edge technical innovation, to improve diagnostic accuracy and enhance clinical care for cancer patients. The company has developed its expertise since its establishment in 2022, building on decades of combined experience of its founders. We conduct research and development, certification and marketing of software solutions for molecular tumour classification based on DNA methylation profiling and machine learning. Epigenetics, CNS tumours, Brain tumours, Pathology, Precision medicine, and Artificial Intelligence

182 similar entities Type: Startup Activities: deeptech Technologies: A.I.

Bridge for Cross-border Win-Win Collaboration in the Healthcare Industry Cenponts is a healthcare investment bank with global presence, particularly in ASIAN Market. Team presence: Paris, Shenzhen, Chengdu, Suzhou, Tokyo, Indianapolis. healthcare, medtech, biotech, diagnostics, aesthetics, cell therapy, CRO, and investment

170 similar entities Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology